Injuries from toys are often the result of
substandard manufacturing practices, and inadequate premarket testing.
In 2010, however, FDA inspectors who examined Hyland's facilities criticized the company for
substandard manufacturing practices and found inconsistent levels of atropa belladonna in its products.
Not exact matches
Ranbaxy USA Inc., the American subsidiary of Ranbaxy Laboratories Limited, an Indian generic pharmaceutical maker, has agreed to pay $ 500 million to settle fines related to claims that it made false statements to the FDA about its
manufacturing practices abroad and sold
substandard medications and pay penalties.